Harvard Stem Cell Institute:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Harvard Stem Cell Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9274
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Harvard Stem Cell Institute (HSCI) a subsidiary of Harvard University is a healthcare institute that conducts research on advance stem cell science using stem cell biology to develop new treatments and cures for disease. The institute provides research programs such as disease programs, core facilities, early-stage research, MD and PhD fellowship, and internship program. It undertakes various disease research programs, which include blood program, cardiovascular program, cancer program, diabetes program, kidney program, nervous system diseases program, and translation research program. The institute also offers clinical trial services. HSCI is headquartered in Cambridge, Massachusetts, the US.

Harvard Stem Cell Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Qatar Biomedical Research Institute Enters into Partnership with Harvard Stem Cell Institute 10
Bristol-Myers Squibb Enters into Research Agreement with Harvard Stem Cell Institute 11
Thrive Bioscience and Harvard Stem Cell Institute Enter into Agreement 12
Boehringer Ingelheim Enters into Research Agreement with Harvard Stem Cell Institute 13
AstraZeneca Enters into Research Agreement with Harvard Stem Cell Institute 14
Evotec Enters Into Research Agreement With Harvard Stem Cell Institute For Amyotrophic Lateral Sclerosis 15
Harvard Stem Cell Institute – Key Competitors 16
Harvard Stem Cell Institute – Key Employees 17
Harvard Stem Cell Institute – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Government and Public Interest 19
Dec 04, 2017: Targeting the bone marrow to drive brain repair after radiation injury 19
Jul 10, 2017: New approach shows promising results for stem cell-based therapy for skin-to-brain cancer in preclinical models 20
Apr 14, 2017: Compound protects nerve cells targeted by neurodegenerative diseases 21
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare, Key Facts 2
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Harvard Stem Cell Institute, Deals By Therapy Area, 2012 to YTD 2018 8
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Qatar Biomedical Research Institute Enters into Partnership with Harvard Stem Cell Institute 10
Bristol-Myers Squibb Enters into Research Agreement with Harvard Stem Cell Institute 11
Thrive Bioscience and Harvard Stem Cell Institute Enter into Agreement 12
Boehringer Ingelheim Enters into Research Agreement with Harvard Stem Cell Institute 13
AstraZeneca Enters into Research Agreement with Harvard Stem Cell Institute 14
Evotec Enters Into Research Agreement With Harvard Stem Cell Institute For Amyotrophic Lateral Sclerosis 15
Harvard Stem Cell Institute, Key Competitors 16
Harvard Stem Cell Institute, Key Employees 17

List of Figures
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Harvard Stem Cell Institute:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bachem Holding AG (BANB):製薬・医療:M&Aディール及び事業提携情報
    Summary Bachem Holding AG (Bachem) is a technology-based biochemical company which develops and manufactures peptides and complex organic molecules including active pharmaceutical ingredients and biochemicals for research purposes. Bachem offers its products and services to the pharmaceutical and bi …
  • Steris Plc (STE):医療機器:M&Aディール及び事業提携情報
    Summary Steris Plc (Steris), formerly Steris Ltd is a medical equipment company that provides infection prevention and other procedural products. The company offers products such as OR integration systems, sterilizers, surgical tables and lights, perioperative solutions, endoscopy accessories and ba …
  • Al Ain Ahlia Insurance Company PSC:企業の戦略・SWOT・財務分析
    Al Ain Ahlia Insurance Company PSC - Strategy, SWOT and Corporate Finance Report Summary Al Ain Ahlia Insurance Company PSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Axela Inc:医療機器:M&Aディール及び事業提携情報
    Summary Axela Inc (Axela), formerly Axela Biosensors Inc is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors, panelPlus sensors and software products. It offers technical and …
  • Carlsberg A/S:企業の戦略・SWOT・財務情報
    Carlsberg A/S - Strategy, SWOT and Corporate Finance Report Summary Carlsberg A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Occidental Chemical Corp:企業の戦略的SWOT分析
    Occidental Chemical Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Duke Energy Carolinas LLC:企業の戦略的SWOT分析
    Duke Energy Carolinas LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • North Eastern Electric Power Corporation Ltd-エネルギー分野:企業M&A・提携分析
    Summary North Eastern Electric Power Corporation Limited (NEEPCO) is a government owned electric utility that generates, procures and sells electricity. The company designs, constructs, operates and maintains hydro, thermal and gas projects. NEEPCO generates electricity from hydro, thermal, and sola …
  • One Call Care Management Inc:医療機器:M&Aディール及び事業提携情報
    Summary One Call Care Management Inc (OCCM), formerly One Call Medical Inc, is a healthcare technology provider that provides specialized cost containment services. The company offers diagnostics, dental, transport, complex home care, equipment and physical therapy, among others. It provides value a …
  • First Bank Of Nigeria Ltd
    First Bank Of Nigeria Ltd - Strategy, SWOT and Corporate Finance Report Summary First Bank Of Nigeria Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Itau Unibanco Holding SA:企業のM&A・事業提携・投資動向
    Itau Unibanco Holding SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Itau Unibanco Holding SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Business Connexion Group Limited:企業の戦略的SWOT分析
    Business Connexion Group Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • The Great-West Life Assurance Co:電力:M&Aディール及び事業提携情報
    Summary The Great-West Life Assurance Co (Great-West Life), a subsidiary of Great-West Lifeco Inc., focuses on life insurance, health insurance, retirement savings, investments, and reinsurance businesses. For individuals, it offers life insurance, disability insurance, critical illness insurance, h …
  • BrainScope Company Inc-医療機器分野:企業M&A・提携分析
    Summary BrainScope Company Inc (BrainScope) is a medical device company that offers medical neurotechnology products. The company develops and distributes non-invasive instruments for the treatment of traumatic brain injuries, moderate traumatic brain injury and mild traumatic brain injury. It provi …
  • Sun Pharmaceutical Industries Ltd (SUNPHARMA):製薬・医療:M&Aディール及び事業提携情報
    Summary Sun Pharmaceutical Industries Ltd (Sun Pharma) is a specialty pharmaceutical company, which offers a wide range of pharmaceutical formulations such as branded generics and generic pharmaceuticals. The company’s products find application in the treatment of various conditions related to psych …
  • OmniComm Systems Inc (OMCM):企業の財務・戦略的SWOT分析
    OmniComm Systems Inc (OMCM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Implants International Ltd:企業の製品パイプライン分析
    Summary Implants International Ltd (Implants International) is a medical device company that manufactures, designs, and develops orthopedic implants, bio-engineering, and other products for the healthcare sector. The company’s products include revision systems, hip stems, hip stem ancillaries, aceta …
  • Globo Comunicacao e Participacoes S.A.:企業の戦略的SWOT分析
    Globo Comunicacao e Participacoes S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Nine Dragons Paper (Holdings) Ltd:企業の戦略・SWOT・財務情報
    Nine Dragons Paper (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report Summary Nine Dragons Paper (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • LegoChem Biosciences Inc (141080):企業の財務・戦略的SWOT分析
    Summary LegoChem Biosciences Inc (LCB) is a bio pharmaceutical company that develops next generation novel therapeutics. The company utilizes its proprietary medicinal drug discovery technology LegoChemistry and ADC platform technology ConjuAll. It manufactures drugs in the therapeutic areas of anti …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆